This topic contains a solution. Click here to go to the answer

Author Question: The nurse is caring for a patient who has rheumatoid arthritis and who is receiving infliximab ... (Read 47 times)

danielfitts88

  • Hero Member
  • *****
  • Posts: 535
The nurse is caring for a patient who has rheumatoid arthritis and who is receiving infliximab (Remicade) IV every 8 weeks. Which laboratory test will the nurse anticipate that this patient will need?
 
  a. Calcium level
  b. Complete blood count
  c. Electrolytes
  d. Potassium

Question 2

Which antigout medication is used to treat chronic tophaceous gout?
 
  a. Allopurinol (Zyloprim)
  b. Colchicine
  c. Probenecid (Benemid)
  d. Sulfinpyrazone (Anturane)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

janieazgirl

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

ANS: B
Infliximab is an immunomodulator and can cause agranulocytosis, so patients should have regular CBC evaluation.

Answer to Question 2

ANS: A
Allopurinol inhibits the biosynthesis of uric acid and is used long-term to manage chronic gout. Colchicine does not inhibit uric acid synthesis or promote uric acid secretion and is not used for chronic gout. Probenecid can be used for chronic gout but is not the first choice. Sulfinpyrazone has many serious side effects.




danielfitts88

  • Member
  • Posts: 535
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


adammoses97

  • Member
  • Posts: 337
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

For a complete list of videos, visit our video library